Comparison of Efficacy and Adverse Effects Between Methimazole 15 mg+Inorganic Iodine 38 mg/Day and Methimazole 30 mg/Day as Initial Therapy for Graves' Disease Patients with Moderate to Severe Hyperthyroidism-Reference-Cited by-同舟云学术

Comparison of Efficacy and Adverse Effects Between Methimazole 15 mg+Inorganic Iodine 38 mg/Day and Methimazole 30 mg/Day as Initial Therapy for Graves' Disease Patients with Moderate to Severe Hyperthyroidism

Published:2015-01 Issue:1 Volume:25 Page:43-50
ISSN:1050-7256
Container-title:Thyroid
language:en
Short-container-title:Thyroid

Author:

Sato Shotaro¹²,Noh Jaeduk Yoshimura¹,Sato Shiori¹,Suzuki Miho¹,Yasuda Shigemitsu¹,Matsumoto Masako¹,Kunii Yo¹,Mukasa Koji¹,Sugino Kiminori¹,Ito Koichi¹,Nagataki Shigenobu¹,Taniyama Matsuo²

Affiliation:

1. Department of Internal Medicine, Ito Hospital, Tokyo, Japan.

2. Division of Endocrinology and Metabolism, Department of Internal Medicine, Showa University Fujigaoka Hospital, Yokohama, Japan.

Publisher

Mary Ann Liebert Inc

Subject

Endocrinology,Endocrinology, Diabetes and Metabolism

Link

https://www.liebertpub.com/doi/pdf/10.1089/thy.2014.0084

Reference24 articles.

1. Comparison of Methimazole and Propylthiouracil in Patients with Hyperthyroidism Caused by Graves’ Disease

2. A comparison of 20 or 40 mg per day of carbimazole in the initial treatment of hyperthyroidism